These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 19822551)
1. Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment. Hontelez JA; Hahné S; Koedijk FH; de Melker HE J Epidemiol Community Health; 2010 Oct; 64(10):890-4. PubMed ID: 19822551 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine. Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088 [TBL] [Abstract][Full Text] [Related]
3. [Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme]. Boot HJ; Schouls L; Hahné S; Berbers GA; van de Laar M; Kimman TG Ned Tijdschr Geneeskd; 2007 Jan; 151(3):172-6. PubMed ID: 17288341 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L; Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171 [TBL] [Abstract][Full Text] [Related]
5. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses. Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692 [TBL] [Abstract][Full Text] [Related]
6. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252 [TBL] [Abstract][Full Text] [Related]
7. Parental attitude towards childhood HBV vaccination in The Netherlands. Hontelez JA; Hahné SJ; Oomen P; de Melker H Vaccine; 2010 Jan; 28(4):1015-20. PubMed ID: 19931384 [TBL] [Abstract][Full Text] [Related]
8. Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia. Wong SL; Soosai P; Teoh YL; Han HH; Lefevre I; Bock HL Southeast Asian J Trop Med Public Health; 2008 May; 39(3):474-83. PubMed ID: 18564687 [TBL] [Abstract][Full Text] [Related]
9. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines. Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study. Monge S; Hahné SJ; de Melker HE; Sanders EA; van der Ende A; Knol MJ Lancet Infect Dis; 2018 Jul; 18(7):749-757. PubMed ID: 29752131 [TBL] [Abstract][Full Text] [Related]
11. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896 [TBL] [Abstract][Full Text] [Related]
12. Public health impact of Infanrix hexa (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population - the PopCorn study. Gaudelus J; Vié le Sage F; Dufour V; Lert F; Texier N; Pouriel M; Tehard B; Bréart G Rev Epidemiol Sante Publique; 2016 Feb; 64(1):23-32. PubMed ID: 26748972 [TBL] [Abstract][Full Text] [Related]
13. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452 [TBL] [Abstract][Full Text] [Related]
15. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV Combination vaccine co-administered with a Hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age. Gabutti G; Zepp F; Schuerman L; Dentico P; Bamfi F; Soncini R; Habermehl P; Knuf M; Crovari P; Scand J Infect Dis; 2004; 36(8):585-92. PubMed ID: 15370670 [TBL] [Abstract][Full Text] [Related]
17. [Long-term efficacy of infant hepatitis B immunization program]. Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973 [TBL] [Abstract][Full Text] [Related]
19. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173 [TBL] [Abstract][Full Text] [Related]
20. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]